(Q63728608)
Statements
Continuous therapy with certolizumab pegol maintains remission of patients with Crohn's disease for up to 18 months (English)
Stephen B Hanauer
Gary R Lichtenstein
William J Sandborn
Ian C Lawrance
Ralph Bloomfield
Stefan Schreiber
Ole Ø Thomsen
Precise 3 Study Investigators